Immune Globulin

Jim Lichauer, Meryl Biksacky, and Conor Hanrahan discuss the strategies Intermountain Healthcare implemented to improve their immune globulin utilization. Guest speaker: Meryl Biksacky, PharmD Pharmacist, Drug Information Specialist Drug Shortage Management CO-Lead Intermountain Healthcare Drug Information Services Conor Hanrahan, PharmD, MS, BCPS, CPHQ Medication Policy, Outcomes and Stewardship Director System PGY1 Pharmacy Residency Program Director Intermountain Healthcare Pharmacy Services Moderator: Jim Lichauer, PharmD, BCPS, FASHP Sr Performance Improvement Program Director, Pharmacy Vizient Show Notes: [01:50] Intermountain Healthcare is a complex system. [03:19] Challenges included the size and scale of the organization, drug shortages, as well as technology and data capture issues. [05:30] The development of IG appropriate use guidelines was intricate and enterprise-wide. [08:21] A medication use evaluation was conducted. [10:08] Evaluation of adherence to weight-based dosing strategies produced shocking results. [11:41] Surveying stakeholders revealed a lack of awareness of internal guidelines and standards. [12:42] A formal policy to optimize IG weight-based dosing is in the process of being approved. [13:35] Advice for those planning similar strategies includes system-wide collaboration, establishing and monitoring adherence rates, standardization, and quantification of cost savings. [15:12] Intermountain Healthcare has exciting developments on the horizon. Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Google Podcasts Android Stitcher RSS Feed